Medicine

In April 2025, guselkumab, a human monoclonal antibody targeting the interleukin-23 (IL-23) pathway, received approval for the treatment of adults...

In a groundbreaking study poised to transform our understanding and treatment of cerebral cavernous malformations (CCMs), researchers at the Perelman...

In a groundbreaking development poised to revolutionize chronic disease treatment, a coalition of scientists from Northwestern University, Rice University, and...

A groundbreaking study led by UCLA Health, recently published in the prestigious journal Cell, marks a pivotal advancement in the...

In recent years, the complex cellular landscape within tumors has unveiled layers of immune interaction that dictate cancer progression, response...

Reston, VA (March 27, 2026) — In an era where precision medicine continues to reshape the horizons of diagnosis and...

In the intricate architecture of the brain, the ability to form and recall precise environmental representations is fundamental to memory...

In a groundbreaking exploration into the mechanisms driving muscle repair, recent research has illuminated the pivotal role of the cannabinoid...

In the relentless arms race between pathogens and the human immune system, Methicillin-Resistant Staphylococcus aureus (MRSA) remains a formidable adversary....

In the rapidly evolving field of metagenomics, the quest to reconstruct complete microbial genomes from complex environmental samples has long...